Annual Report of Proxy Voting Record for Management Investment Companies (n-px)
19 August 2022 - 02:43PM
Edgar (US Regulatory)
|
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL |
|
OMB
Number: 3235-0582 |
|
Expires: July 31, 2024 |
|
Estimated average burden |
|
hours per response........4 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 06565
Tekla Healthcare Opportunites Fund
(Exact name of registrant as specified in charter)
100 Federal Street, 19th Floor, Boston,
MA |
|
02110 |
(Address of
principal executive offices) |
|
(Zip code) |
Laura Woodward
Tekla Healthcare Opportunities Fund
100 Federal Street, 19th Floor, Boston MA
02110
(Name and address of agent for service)
Registrant’s telephone number, including area
code: 617-772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/21-6/30/22
Form N-PX is to be used by a registered management investment
company, other than a small business investment company registered
on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file
reports with the Commission, no later than August 31 of each
year, containing the registrant’s proxy voting record for the most
recent twelve-month period ended June 30, pursuant to section
30 of the Investment Company Act of 1940 and rule 30b1-4
thereunder (17 CFR 270.30b1-4). The Commission may use the
information provided on Form N-PX in its regulatory,
disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by
Form N-PX, and the Commission will make this information
public. A registrant is not required to respond to the collection
of information contained in Form N-PX unless the
Form displays a currently valid Office of Management and
Budget (“OMB”) control number. Please direct comments concerning
the accuracy of the information collection burden estimate and any
suggestions for reducing the burden to the Secretary, Securities
and Exchange Commission, 450 Fifth Street, NW, Washington, DC
20549-0609. The OMB has reviewed this collection of information
under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
Vote Summary
1LIFE HEALTHCARE, INC.
Security |
68269G107 |
Meeting
Type |
Special |
Ticker
Symbol |
ONEM |
Meeting
Date |
27-Aug-2021 |
Record
Date |
13-Jul-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
To
approve the issuance of shares of common stock, $0.001 par value
per share, of 1Life Healthcare, Inc. to stockholders of Iora
Health, Inc. in connection with the merger contemplated by the
Agreement and Plan of Merger, dated June 6, 2021, among 1Life
Healthcare, Inc., SB Merger Sub, Inc., Iora
Health, Inc. and Fortis Advisors LLC, solely in its capacity
as the representative of the stockholders of Iora. |
|
Management |
|
For |
|
For |
|
2. |
|
To
approve adjournments of the 1Life special meeting, if necessary and
appropriate, to solicit additional proxies if there are not
sufficient votes to approve the 1Life stock issuance
proposal. |
|
Management |
|
For |
|
For |
|
1LIFE HEALTHCARE, INC.
Security |
68269G107 |
Meeting
Type |
Annual |
Ticker
Symbol |
ONEM |
Meeting
Date |
02-Jun-2022 |
Record
Date |
04-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
Paul
R. Auvil |
|
|
|
For |
|
For |
|
|
|
2. |
Mark
S. Blumenkranz, MD |
|
|
|
For |
|
For |
|
|
|
3. |
Kalen
F. Holmes, Ph.D. |
|
|
|
For |
|
For |
|
2. |
|
To
ratify the appointment of PricewaterhouseCoopers LLP as our
independent registered public accounting firm for our fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve, on a non-binding advisory basis, the compensation of our
named executive officers. |
|
Management |
|
For |
|
For |
|
4. |
|
To
approve, on a non-binding advisory basis, the frequency of future
non-binding stockholder advisory votes on the compensation of our
named executive officers. |
|
Management |
|
1
Year |
|
For |
|
ABBOTT LABORATORIES
Security |
002824100 |
Meeting
Type |
Annual |
Ticker
Symbol |
ABT |
Meeting
Date |
29-Apr-2022 |
Record
Date |
02-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
R. J.
Alpern |
|
|
|
For |
|
For |
|
|
|
2. |
S. E.
Blount |
|
|
|
For |
|
For |
|
|
|
3. |
R. B.
Ford |
|
|
|
For |
|
For |
|
|
|
4. |
P.
Gonzalez |
|
|
|
For |
|
For |
|
|
|
5. |
M. A.
Kumbier |
|
|
|
For |
|
For |
|
|
|
6. |
D. W.
McDew |
|
|
|
For |
|
For |
|
|
|
7. |
N.
McKinstry |
|
|
|
For |
|
For |
|
|
|
8. |
W. A.
Osborn |
|
|
|
For |
|
For |
|
|
|
9. |
M. F.
Roman |
|
|
|
For |
|
For |
|
|
|
10. |
D. J.
Starks |
|
|
|
For |
|
For |
|
|
|
11. |
J. G.
Stratton |
|
|
|
For |
|
For |
|
|
|
12. |
G. F.
Tilton |
|
|
|
For |
|
For |
|
2. |
|
Ratification
of Ernst & Young LLP As Auditors |
|
Management |
|
For |
|
For |
|
3. |
|
Say
on Pay - An Advisory Vote on the Approval of Executive
Compensation |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder
Proposal - Special Shareholder Meeting Threshold |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Shareholder
Proposal - Independent Board Chairman |
|
Shareholder |
|
For |
|
Against |
|
6. |
|
Shareholder
Proposal - Rule 10b5-1 Plans |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Shareholder
Proposal - Lobbying Disclosure |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
Shareholder
Proposal - Antimicrobial Resistance Report |
|
Shareholder |
|
Against |
|
For |
|
ABBVIE INC.
Security |
00287Y109 |
Meeting
Type |
Annual |
Ticker
Symbol |
ABBV |
Meeting
Date |
06-May-2022 |
Record
Date |
07-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
William
H.L. Burnside |
|
|
|
For |
|
For |
|
|
|
2. |
Thomas
C. Freyman |
|
|
|
For |
|
For |
|
|
|
3. |
Brett
J. Hart |
|
|
|
For |
|
For |
|
|
|
4. |
Edward
J. Rapp |
|
|
|
For |
|
For |
|
2. |
|
Ratification
of Ernst & Young LLP as AbbVie's independent registered
public accounting firm for 2022 |
|
Management |
|
For |
|
For |
|
3. |
|
Say
on Pay - An advisory vote on the approval of executive
compensation |
|
Management |
|
For |
|
For |
|
4. |
|
Approval
of a management proposal regarding amendment of the certificate of
incorporation to eliminate supermajority voting |
|
Management |
|
For |
|
For |
|
5. |
|
Stockholder
Proposal - to Adopt a Policy to Require Independent
Chairman |
|
Shareholder |
|
For |
|
Against |
|
6. |
|
Stockholder
Proposal - to Seek Shareholder Approval of Certain Termination Pay
Arrangements |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Stockholder
Proposal - to Issue a Report on Board Oversight of Competition
Practices |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
Stockholder
Proposal - to Issue an Annual Report on Political
Spending |
|
Shareholder |
|
Against |
|
For |
|
ACADIA HEALTHCARE COMPANY, INC.
Security |
00404A109 |
Meeting
Type |
Annual |
Ticker
Symbol |
ACHC |
Meeting
Date |
19-May-2022 |
Record
Date |
24-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Jason R. Bernhard |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: William F. Grieco |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Reeve B. Waud |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory
vote on the compensation of the Company's named executive officers
as presented in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratify
the appointment of Ernst & Young LLP as the Company's
independent registered public accounting firm for the fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
ADDUS HOMECARE CORPORATION
Security |
006739106 |
Meeting
Type |
Annual |
Ticker
Symbol |
ADUS |
Meeting
Date |
15-Jun-2022 |
Record
Date |
22-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
Esteban
López, M.D. |
|
|
|
For |
|
For |
|
|
|
2. |
Jean
Rush |
|
|
|
For |
|
For |
|
|
|
3. |
Susan
T. Weaver MD FACP |
|
|
|
For |
|
For |
|
2. |
|
To
ratify the appointment of PricewaterhouseCoopers LLP, an
independent registered public accounting firm, as our independent
auditor for the fiscal year ending December 31,
2022. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve, on an advisory, non-binding basis, the compensation of the
named executive officers. |
|
Management |
|
For |
|
For |
|
AGILENT TECHNOLOGIES, INC.
Security |
00846U101 |
Meeting
Type |
Annual |
Ticker
Symbol |
A |
Meeting
Date |
16-Mar-2022 |
Record
Date |
18-Jan-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Director for a three-year term: Hans E. Bishop |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Director for a three-year term: Otis W. Brawley,
M.D. |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Director for a three-year term: Mikael Dolsten, M.D.,
Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
To
approve, on a non-binding advisory basis, the compensation of our
named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To
ratify the Audit and Finance Committee's appointment of
PricewaterhouseCoopers LLP as our independent registered public
accounting firm. |
|
Management |
|
For |
|
For |
|
4. |
|
To
vote on a stockholder proposal regarding the right to call a
special meeting, if properly presented at the meeting. |
|
Management |
|
Against |
|
For |
|
ALERISLIFE, INC.
Security |
33832D205 |
Meeting
Type |
Annual |
Ticker
Symbol |
ALR |
Meeting
Date |
07-Jun-2022 |
Record
Date |
22-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Director: Jennifer B. Clark (for Managing Director in Group
III) |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Director: Bruce M. Gans, M.D. (for Independent Director in Group
III) |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Director: Michael E. Wagner, M.D. (for Independent Director in
Group III) |
|
Management |
|
For |
|
For |
|
2. |
|
Approval
of the Second Amended and Restated 2014 Equity Compensation
Plan. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification
of the appointment of Deloitte & Touche LLP as independent
auditors to serve for the 2022 fiscal year. |
|
Management |
|
For |
|
For |
|
ALIGN TECHNOLOGY, INC.
Security |
016255101 |
Meeting
Type |
Annual |
Ticker
Symbol |
ALGN |
Meeting
Date |
18-May-2022 |
Record
Date |
23-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1a. |
|
Election
of Director: Kevin J. Dallas |
|
Management |
|
For |
|
For |
|
1b. |
|
Election
of Director: Joseph M. Hogan |
|
Management |
|
For |
|
For |
|
1c. |
|
Election
of Director: Joseph Lacob |
|
Management |
|
For |
|
For |
|
1d. |
|
Election
of Director: C. Raymond Larkin, Jr. |
|
Management |
|
For |
|
For |
|
1e. |
|
Election
of Director: George J. Morrow |
|
Management |
|
For |
|
For |
|
1f. |
|
Election
of Director: Anne M. Myong |
|
Management |
|
For |
|
For |
|
1g. |
|
Election
of Director: Andrea L. Saia |
|
Management |
|
For |
|
For |
|
1h. |
|
Election
of Director: Greg J. Santora |
|
Management |
|
For |
|
For |
|
1i. |
|
Election
of Director: Susan E. Siegel |
|
Management |
|
For |
|
For |
|
1j. |
|
Election
of Director: Warren S. Thaler |
|
Management |
|
For |
|
For |
|
2. |
|
RATIFICATION
OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS:
Proposal to ratify the appointment of PricewaterhouseCoopers LLP as
Align Technology, Inc.'s independent registered public
accountants for the fiscal year ending December 31,
2022. |
|
Management |
|
For |
|
For |
|
3. |
|
ADVISORY
VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to
Approve the Compensation of our Named Executive
Officers. |
|
Management |
|
For |
|
For |
|
AMGEN, INC.
Security |
031162100 |
Meeting
Type |
Annual |
Ticker
Symbol |
AMGN |
Meeting
Date |
17-May-2022 |
Record
Date |
18-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Dr. Wanda M. Austin |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Mr. Robert A. Bradway |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Dr. Brian J. Druker |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Mr. Robert A. Eckert |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Mr. Greg C. Garland |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Mr. Charles M. Holley, Jr. |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Dr. S. Omar Ishrak |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Dr. Tyler Jacks |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Ms. Ellen J. Kullman |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Ms. Amy E. Miles |
|
Management |
|
For |
|
For |
|
1K. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Dr. Ronald D. Sugar |
|
Management |
|
For |
|
For |
|
1L. |
|
Election
of Director for a term of expiring at the 2023 annual meeting:
Dr. R. Sanders Williams |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory
vote to approve our executive compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
To
ratify the selection of Ernst & Young LLP as our
independent registered public accountants for the fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
AMN HEALTHCARE SERVICES, INC.
Security |
001744101 |
Meeting
Type |
Annual |
Ticker
Symbol |
AMN |
Meeting
Date |
06-May-2022 |
Record
Date |
14-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Jorge A. Caballero |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Mark G. Foletta |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Teri G. Fontenot |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: R. Jeffrey Harris |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Daphne E. Jones |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Martha H. Marsh |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Susan R. Salka |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Sylvia Trent-Adams |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Douglas D. Wheat |
|
Management |
|
For |
|
For |
|
2. |
|
To
approve, by non-binding advisory vote, the compensation of the
Company's named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve the AMN Healthcare Employee Stock Purchase
Plan. |
|
Management |
|
For |
|
For |
|
4. |
|
To
ratify the appointment of KPMG LLP as the Company's independent
registered public accounting firm for the fiscal year ending
December 31, 2022. |
|
Management |
|
For |
|
For |
|
5. |
|
A
shareholder proposal entitled: "Special Shareholder Meeting
Improvement". |
|
Shareholder |
|
Against |
|
For |
|
Security |
036752103 |
Meeting
Type |
Annual |
Ticker
Symbol |
ANTM |
Meeting
Date |
18-May-2022 |
Record
Date |
17-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Director: Susan D. DeVore |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Director: Bahija Jallal |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Director: Ryan M. Schneider |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election
of Director: Elizabeth E. Tallett |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory
vote to approve the compensation of our named executive
officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To
ratify the appointment of Ernst & Young LLP as the
independent registered public accounting firm for 2022. |
|
Management |
|
For |
|
For |
|
4. |
|
To
approve an amendment to our Articles of Incorporation to change our
name to Elevance Health, Inc. |
|
Management |
|
For |
|
For |
|
5. |
|
Shareholder
proposal to prohibit political funding. |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
Shareholder
proposal requesting a racial impact audit and report. |
|
Shareholder |
|
Against |
|
For |
|
Security |
04546C205 |
Meeting
Type |
Annual |
Ticker
Symbol |
ASRT |
Meeting
Date |
04-May-2022 |
Record
Date |
28-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Director to serve until the 2023 Annual Meeting of Stockholders:
Heather L. Mason |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Director to serve until the 2023 Annual Meeting of Stockholders:
William T. McKee |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Director to serve until the 2023 Annual Meeting of Stockholders:
Daniel A. Peisert |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election
of Director to serve until the 2023 Annual Meeting of Stockholders:
Peter D. Staple |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election
of Director to serve until the 2023 Annual Meeting of Stockholders:
James L. Tyree |
|
Management |
|
For |
|
For |
|
2. |
|
To
approve an amendment and restatement of Assertio's Amended and
Restated 2014 Omnibus Incentive Plan, including an increase in the
number of shares available for issuance thereunder. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve, on an advisory basis, the compensation of Assertio's named
executive officers. |
|
Management |
|
For |
|
For |
|
4. |
|
To
ratify the appointment of Grant Thornton LLP as Assertio's
independent registered public accounting firm for the fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
Security |
046353108 |
Meeting
Type |
Annual |
Ticker
Symbol |
AZN |
Meeting
Date |
29-Apr-2022 |
Record
Date |
07-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
To
receive the Company's Accounts, the Reports of the Directors and
Auditor and the Strategic Report for the year ended 31
December 2021 |
|
Management |
|
For |
|
For |
|
2. |
|
To
confirm dividends |
|
Management |
|
For |
|
For |
|
3. |
|
To
reappoint PricewaterhouseCoopers LLP as Auditor |
|
Management |
|
For |
|
For |
|
4. |
|
To
authorise the Directors to agree the remuneration of the
Auditor |
|
Management |
|
For |
|
For |
|
5A. |
|
Re-election
of Director: Leif Johansson |
|
Management |
|
For |
|
For |
|
5B. |
|
Re-election
of Director: Pascal Soriot |
|
Management |
|
For |
|
For |
|
5C. |
|
Election
of Director: Aradhana Sarin |
|
Management |
|
For |
|
For |
|
5D. |
|
Re-election
of Director: Philip Broadley |
|
Management |
|
For |
|
For |
|
5E. |
|
Re-election
of Director: Euan Ashley |
|
Management |
|
For |
|
For |
|
5F. |
|
Re-election
of Director: Michel Demaré |
|
Management |
|
For |
|
For |
|
5G. |
|
Re-election
of Director: Deborah DiSanzo |
|
Management |
|
For |
|
For |
|
5H. |
|
Re-election
of Director: Diana Layfield |
|
Management |
|
For |
|
For |
|
5I. |
|
Re-election
of Director: Sheri McCoy |
|
Management |
|
For |
|
For |
|
5J. |
|
Re-election
of Director: Tony Mok |
|
Management |
|
For |
|
For |
|
5K. |
|
Re-election
of Director: Nazneen Rahman |
|
Management |
|
For |
|
For |
|
5L. |
|
Election
of Director: Andreas Rummelt |
|
Management |
|
For |
|
For |
|
5M. |
|
Re-election
of Director: Marcus Wallenberg |
|
Management |
|
For |
|
For |
|
6. |
|
To
approve the Annual Report on Remuneration for the year ended 31
December 2021 |
|
Management |
|
For |
|
For |
|
7. |
|
To
authorise limited political donations |
|
Management |
|
For |
|
For |
|
8. |
|
To
authorise the Directors to allot shares |
|
Management |
|
For |
|
For |
|
9. |
|
To
authorise the Directors to disapply pre-emption rights (Special
Resolution) |
|
Management |
|
For |
|
For |
|
10. |
|
To
authorise the Directors to further disapply pre-emption rights for
acquisitions and specified capital investments (Special
Resolution) |
|
Management |
|
For |
|
For |
|
11. |
|
To
authorise the Company to purchase its own shares (Special
Resolution) |
|
Management |
|
For |
|
For |
|
12. |
|
To
reduce the notice period for general meetings (Special
Resolution) |
|
Management |
|
For |
|
For |
|
13. |
|
To
extend the AstraZenca PLC 2012 Savings Related Share Option
Scheme |
|
Management |
|
For |
|
For |
|
BECTON,
DICKINSON AND
COMPANY
Security |
075887109 |
Meeting
Type |
Annual |
Ticker
Symbol |
BDX |
Meeting
Date |
25-Jan-2022 |
Record
Date |
06-Dec-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Catherine M. Burzik |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Carrie L. Byington |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: R. Andrew Eckert |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Claire M. Fraser |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Jeffrey W. Henderson |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Christopher Jones |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Marshall O. Larsen |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: David F. Melcher |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Thomas E. Polen |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: Claire Pomeroy |
|
Management |
|
For |
|
For |
|
1K. |
|
Election
of Director: Timothy M. Ring |
|
Management |
|
For |
|
For |
|
1L. |
|
Election
of Director: Bertram L. Scott |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of the selection of the independent registered public accounting
firm. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
A
shareholder proposal seeking to lower the ownership threshold
required to call a special shareholders meeting, if properly
presented at the meeting. |
|
Shareholder |
|
Against |
|
For |
|
Security |
09073M104 |
Meeting
Type |
Annual |
Ticker
Symbol |
TECH |
Meeting
Date |
28-Oct-2021 |
Record
Date |
03-Sep-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
To
set the number of Directors at nine. |
|
Management |
|
For |
|
For |
|
2A. |
|
Election
of Director: Robert V. Baumgartner |
|
Management |
|
For |
|
For |
|
2B. |
|
Election
of Director: Julie L. Bushman |
|
Management |
|
For |
|
For |
|
2C. |
|
Election
of Director: John L. Higgins |
|
Management |
|
For |
|
For |
|
2D. |
|
Election
of Director: Joseph D. Keegan |
|
Management |
|
For |
|
For |
|
2E. |
|
Election
of Director: Charles R. Kummeth |
|
Management |
|
For |
|
For |
|
2F. |
|
Election
of Director: Roeland Nusse |
|
Management |
|
For |
|
For |
|
2G. |
|
Election
of Director: Alpna Seth |
|
Management |
|
For |
|
For |
|
2H. |
|
Election
of Director: Randolph Steer |
|
Management |
|
For |
|
For |
|
2I. |
|
Election
of Director: Rupert Vessey |
|
Management |
|
For |
|
For |
|
3. |
|
Cast
a non-binding vote on named executive officer
compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Ratify
the appointment of the Company's independent registered public
accounting firm for the 2022 fiscal year. |
|
Management |
|
For |
|
For |
|
Security |
09062X103 |
Meeting
Type |
Annual |
Ticker
Symbol |
BIIB |
Meeting
Date |
15-Jun-2022 |
Record
Date |
21-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1a. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Alexander J. Denner |
|
Management |
|
For |
|
For |
|
1b. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Caroline D. Dorsa |
|
Management |
|
For |
|
For |
|
1c. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Maria C. Freire |
|
Management |
|
For |
|
For |
|
1d. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: William A. Hawkins |
|
Management |
|
For |
|
For |
|
1e. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: William D. Jones |
|
Management |
|
For |
|
For |
|
1f. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Jesus B. Mantas |
|
Management |
|
For |
|
For |
|
1g. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Richard C. Mulligan |
|
Management |
|
For |
|
For |
|
1h. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Stelios Papadopoulos |
|
Management |
|
For |
|
For |
|
1i. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Eric K. Rowinsky |
|
Management |
|
For |
|
For |
|
1j. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Stephen A. Sherwin |
|
Management |
|
For |
|
For |
|
1k. |
|
Election
of Director to serve for a one-year term extending until the 2023
Annual Meeting: Michel Vounatsos |
|
Management |
|
For |
|
For |
|
2. |
|
To
ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s
independent registered public accounting firm for the fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Say
on Pay - To approve an advisory vote on executive
compensation. |
|
Management |
|
For |
|
For |
|
BOSTON
SCIENTIFIC CORPORATION |
Security |
101137107 |
Meeting
Type |
Annual |
Ticker
Symbol |
BSX |
Meeting
Date |
05-May-2022 |
Record
Date |
11-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Nelda J. Connors |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Charles J. Dockendorff |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Yoshiaki Fujimori |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Donna A. James |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Edward J. Ludwig |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Michael F. Mahoney |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: David J. Roux |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: John E. Sununu |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: David S. Wichmann |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: Ellen M. Zane |
|
Management |
|
For |
|
For |
|
2. |
|
To
approve, on a non-binding, advisory basis, named executive officer
compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
To
ratify the appointment of Ernst & Young LLP as our
independent registered public accounting firm for the 2022 fiscal
year. |
|
Management |
|
For |
|
For |
|
4. |
|
To
approve an amendment and restatement of our 2006 Global Employee
Stock Ownership Plan (to be renamed as our Employee Stock Purchase
Plan), as previously amended and restated, including a request for
10,000,000 additional shares. |
|
Management |
|
For |
|
For |
|
BRISTOL-MYERS
SQUIBB COMPANY |
Security |
110122108 |
Meeting
Type |
Annual |
Ticker
Symbol |
BMY |
Meeting
Date |
03-May-2022 |
Record
Date |
14-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A) |
|
Election
of Director: Peter J. Arduini |
|
Management |
|
For |
|
For |
|
1B) |
|
Election
of Director: Giovanni Caforio, M.D. |
|
Management |
|
For |
|
For |
|
1C) |
|
Election
of Director: Julia A. Haller, M.D. |
|
Management |
|
For |
|
For |
|
1D) |
|
Election
of Director: Manuel Hidalgo Medina, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
1E) |
|
Election
of Director: Paula A. Price |
|
Management |
|
For |
|
For |
|
1F) |
|
Election
of Director: Derica W. Rice |
|
Management |
|
For |
|
For |
|
1G) |
|
Election
of Director: Theodore R. Samuels |
|
Management |
|
For |
|
For |
|
1H) |
|
Election
of Director: Gerald L. Storch |
|
Management |
|
For |
|
For |
|
1I) |
|
Election
of Director: Karen H. Vousden, Ph.D. |
|
Management |
|
For |
|
For |
|
1J) |
|
Election
of Director: Phyllis R. Yale |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory
Vote to Approve the Compensation of our Named Executive
Officers. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification
of the Appointment of an Independent Registered Public Accounting
Firm. |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder
Proposal to Lower the Ownership Threshold for Special Shareholder
Meetings to 10%. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Shareholder
Proposal on the Adoption of a Board Policy that the Chairperson of
the Board be an Independent Director. |
|
Shareholder |
|
For |
|
Against |
|
Security |
148806102 |
Meeting
Type |
Annual |
Ticker
Symbol |
CTLT |
Meeting
Date |
28-Oct-2021 |
Record
Date |
03-Sep-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Madhavan Balachandran |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Michael J. Barber |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: J. Martin Carroll |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: John Chiminski |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Rolf Classon |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Rosemary A. Crane |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: John Greisch |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Christa Kreuzburg |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Gregory T. Lucier |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: Donald E. Morel, Jr. |
|
Management |
|
For |
|
For |
|
1K. |
|
Election
of Director: Jack Stahl |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of Appointment of Independent Auditor for Fiscal 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
Vote to Approve Our Executive Compensation
(Say-on-Pay). |
|
Management |
|
For |
|
For |
|
4. |
|
Advisory
Vote on the Frequency of Advisory Votes in Respect of Executive
Compensation. |
|
Management |
|
1
Year |
|
For |
|
5. |
|
Amend
our Certificate of Incorporation to Remove the Limitation on
Calling Shareholder Special Meetings. |
|
Management |
|
For |
|
For |
|
6. |
|
Amend
our Certificate of Incorporation to Add a Federal Forum Selection
Provision. |
|
Management |
|
For |
|
For |
|
7. |
|
Amend
and Restate our Certificate of Incorporation to (i) Eliminate the
Supermajority Vote Requirement for Amendments and (ii) Make
Non-Substantive and Conforming Changes. |
|
Management |
|
For |
|
For |
|
CHARLES RIVER LABORATORIES INTL., INC.
Security |
159864107 |
Meeting Type |
Annual |
Ticker Symbol |
CRL |
Meeting Date |
10-May-2022 |
Record Date |
21-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director: James C.
Foster |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Nancy C.
Andrews |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Robert
Bertolini |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Deborah T.
Kochevar |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: George Llado,
Sr. |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Martin W.
MacKay |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: George E.
Massaro |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: C. Richard
Reese |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Richard F.
Wallman |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: Virginia M.
Wilson |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory approval of 2021 Executive
Compensation |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of
PricewaterhouseCoopers LLC as independent registered accounting
public firm for 2022 |
|
Management |
|
For |
|
For |
|
Security |
125523100 |
Meeting Type |
Annual |
Ticker Symbol |
CI |
Meeting Date |
27-Apr-2022 |
Record Date |
08-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director: David M.
Cordani |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: William J.
DeLaney |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Eric J.
Foss |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Elder
Granger, MD, MG, USA (Retired) |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Neesha
Hathi |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: George
Kurian |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Kathleen M.
Mazzarella |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Mark B.
McClellan, MD, PhD |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Kimberly A.
Ross |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: Eric C.
Wiseman |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director: Donna F.
Zarcone |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory approval of Cigna's
executive compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of the appointment of
PricewaterhouseCoopers LLP as Cigna's independent registered public
accounting firm for 2022. |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder proposal - Special
shareholder meeting improvement. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Shareholder proposal - Gender pay
gap report. |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
Shareholder proposal - Political
contributions report. |
|
Shareholder |
|
Against |
|
For |
|
COMMUNITY HEALTH SYSTEMS, INC. |
Security |
203668108 |
Meeting Type |
Annual |
Ticker Symbol |
CYH |
Meeting Date |
10-May-2022 |
Record Date |
14-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director: Susan W.
Brooks |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: John A.
Clerico |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Michael
Dinkins |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: James S. Ely
III |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: John A.
Fry |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Joseph A.
Hastings, D.M.D. |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Tim L.
Hingtgen |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Elizabeth T.
Hirsch |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: William
Norris Jennings, M.D. |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: K. Ranga
Krishnan, MBBS |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director: Wayne T.
Smith |
|
Management |
|
For |
|
For |
|
1L. |
|
Election of Director: H. James
Williams, Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
Proposal to approve on an advisory
(non-binding) basis the compensation of the Company's named
executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
Proposal to ratify the selection of
Deloitte & Touche LLP as the Company's independent registered
public accounting firm for the fiscal year ending December 31,
2022. |
|
Management |
|
For |
|
For |
|
Security |
126650100 |
Meeting Type |
Annual |
Ticker Symbol |
CVS |
Meeting Date |
11-May-2022 |
Record Date |
14-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director: Fernando
Aguirre |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: C. David
Brown II |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Alecia A.
DeCoudreaux |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Nancy-Ann M.
DeParle |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Roger N.
Farah |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Anne M.
Finucane |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Edward J.
Ludwig |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Karen S.
Lynch |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Jean-Pierre
Millon |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: Mary L.
Schapiro |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director: William C.
Weldon |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of
our independent registered public accounting firm for 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Say on Pay, a proposal to approve,
on an advisory basis, the Company's executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Stockholder proposal for reducing
our ownership threshold to request a special stockholder
meeting. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Stockholder proposal regarding our
independent Board Chair. |
|
Shareholder |
|
For |
|
Against |
|
6. |
|
Stockholder proposal on civil
rights and non- discrimination audit focused on "non-diverse"
employees. |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Stockholder proposal requesting
paid sick leave for all employees. |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
Stockholder proposal regarding a
report on the public health costs of our food business to
diversified portfolios. |
|
Shareholder |
|
Against |
|
For |
|
Security |
235851102 |
Meeting Type |
Annual |
Ticker Symbol |
DHR |
Meeting Date |
10-May-2022 |
Record Date |
11-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Rainer M. Blair |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Linda Filler |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Teri List |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Walter G. Lohr,
Jr. |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Jessica L. Mega, MD,
MPH |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Mitchell P.
Rales |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Steven M. Rales |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Pardis C. Sabeti,
MD, D. PHIL |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: A. Shane
Sanders |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: John T.
Schwieters |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Alan G. Spoon |
|
Management |
|
For |
|
For |
|
1L. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Raymond C. Stevens,
Ph.D |
|
Management |
|
For |
|
For |
|
1M. |
|
Election of Director to hold office
until the 2023 Annual Meeting of Shareholders: Elias A. Zerhouni,
MD |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the selection of Ernst
& Young LLP as Danaher's independent registered public
accounting firm for the year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve on an advisory basis the
Company's named executive officer compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
To act upon a shareholder proposal
requesting that Danaher amend its governing documents to reduce the
percentage of shares required for shareholders to call a special
meeting of shareholders from 25% to 10%. |
|
Shareholder |
|
Against |
|
For |
|
DENTSPLY SIRONA INC.
Security |
24906P109 |
Meeting Type |
Annual |
Ticker Symbol |
XRAY |
Meeting Date |
25-May-2022 |
Record Date |
28-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director: Eric K.
Brandt |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Donald M.
Casey Jr. |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Willie A.
Deese |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: John P.
Groetelaars |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Betsy D.
Holden |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Clyde R.
Hosein |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Harry M.
Kraemer Jr. |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Gregory T.
Lucier |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Leslie F.
Varon |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: Janet S.
Vergis |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director: Dorothea
Wenzel |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of
PricewaterhouseCoopers LLP as the Company's independent registered
public accountants for 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval, by non-binding vote, of
the Company's executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Approval of the Amendment to the
Fifth Amended and Restated By- Laws to Designate the Exclusive
Forum for the Adjudication of Certain Legal Matters. |
|
Management |
|
For |
|
For |
|
Security |
252131107 |
Meeting Type |
Annual |
Ticker Symbol |
DXCM |
Meeting Date |
19-May-2022 |
Record Date |
31-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election of Class II Director to
hold office until our 2023 Annual Meeting: Steven R. Altman |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Class II Director to
hold office until our 2023 Annual Meeting: Barbara E. Kahn |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Class II Director to
hold office until our 2023 Annual Meeting: Kyle Malady |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election of Class II Director to
hold office until our 2023 Annual Meeting: Jay S. Skyler, MD,
MACP |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the selection by the
Audit Committee of our Board of Directors of Ernst & Young LLP
as our independent registered public accounting firm for the fiscal
year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
To hold a non-binding vote on an
advisory resolution to approve executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
To approve the amendment and
restatement of our Restated Certificate of Incorporation to (i)
effect a 4:1 forward split of our Common Stock (the "Forward Stock
Split") and (ii) increase the number of shares of authorized Common
Stock to effectuate the Forward Stock Split. |
|
Management |
|
For |
|
For |
|
DIVERSIFIED HEALTHCARE TRUST |
Security |
25525P107 |
Meeting Type |
Annual |
Ticker Symbol |
DHC |
Meeting Date |
02-Jun-2022 |
Record Date |
22-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Independent Trustee:
Lisa Harris Jones |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Independent Trustee:
John L. Harrington |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Managing Trustee:
Jennifer F. Francis |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Managing Trustee: Adam
D. Portnoy |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory vote to approve executive
compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval of the Amended and
Restated 2012 Equity Compensation Plan. |
|
Management |
|
For |
|
For |
|
4. |
|
Ratification of the appointment of
Deloitte & Touche LLP as independent auditors to serve for the
2022 fiscal year. |
|
Management |
|
For |
|
For |
|
EDWARDS LIFESCIENCES
CORPORATION |
Security |
28176E108 |
Meeting Type |
Annual |
Ticker Symbol |
EW |
Meeting Date |
03-May-2022 |
Record Date |
09-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election of Director: Kieran T.
Gallahue |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: Leslie S.
Heisz |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director: Paul A.
LaViolette |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election of Director: Steven R.
Loranger |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election of Director: Martha H.
Marsh |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election of Director: Michael A.
Mussallem |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election of Director: Ramona
Sequeira |
|
Management |
|
For |
|
For |
|
1.8 |
|
Election of Director: Nicholas J.
Valeriani |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory Vote to Approve Named
Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of Appointment of
Independent Registered Public Accounting Firm |
|
Management |
|
For |
|
For |
|
4. |
|
Stockholder Proposal for an
Advisory Vote to Reduce the Share Ownership Threshold to Call a
Special Meeting |
|
Shareholder |
|
Against |
|
For |
|
Security |
532457108 |
Meeting Type |
Annual |
Ticker Symbol |
LLY |
Meeting Date |
02-May-2022 |
Record Date |
22-Feb-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director to serve a
three-year term: Ralph Alvarez |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director to serve a
three-year term: Kimberly H. Johnson |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director to serve a
three-year term: Juan R. Luciano |
|
Management |
|
For |
|
For |
|
2. |
|
Approval, on an advisory basis, of
the compensation paid to the company's named executive
officers. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of the appointment of
Ernst & Young LLP as the independent auditor for 2022. |
|
Management |
|
For |
|
For |
|
4. |
|
Approval of amendments to the
company's Articles of Incorporation to eliminate the classified
board structure. |
|
Management |
|
For |
|
For |
|
5. |
|
Approval of amendments to the
company's Articles of Incorporation to eliminate supermajority
voting provisions. |
|
Management |
|
For |
|
For |
|
6. |
|
Approval of amendments to the
company's Articles of Incorporation to give shareholders the
ability to amend the company's bylaws. |
|
Management |
|
For |
|
For |
|
7. |
|
Shareholder proposal to amend the
bylaws to require an independent board chair. |
|
Shareholder |
|
For |
|
Against |
|
8. |
|
Shareholder proposal to publish an
annual report disclosing lobbying activities. |
|
Shareholder |
|
Against |
|
For |
|
9. |
|
Shareholder proposal to disclose
lobbying activities and alignment with public policy positions and
statements. |
|
Shareholder |
|
Against |
|
For |
|
10. |
|
Shareholder proposal to report
oversight of risks related to anticompetitive pricing
strategies. |
|
Shareholder |
|
Against |
|
For |
|
ENDEAVOR BIOMEDICINES, INC. |
Security |
N/A |
Meeting Type |
Written Consent |
Ticker Symbol |
N/A |
Meeting Date |
03-Mar-2022 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
Amendment to Amended and Restated
Certificate of Incorporation. |
|
Management |
|
For |
|
For |
|
2. |
|
Amendment to Series B Preferred
Stock Purchase Agreement. |
|
Management |
|
For |
|
For |
|
3. |
|
General Authority and
Ratification. |
|
Management |
|
For |
|
For |
|
GALERA THERAPEUTICS, INC. |
Security |
36338D108 |
Meeting Type |
Annual |
Ticker Symbol |
GRTX |
Meeting Date |
15-Jun-2022 |
Record Date |
22-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
Emmett Cunningham |
|
|
|
For |
|
For |
|
|
|
2. |
J. Mel Sorensen |
|
|
|
For |
|
For |
|
2. |
|
To ratify the
appointment of KPMG LLP as our independent registered public
accounting firm for the fiscal year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
Security |
375558103 |
Meeting Type |
Annual |
Ticker Symbol |
GILD |
Meeting Date |
04-May-2022 |
Record Date |
15-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director: Jacqueline K.
Barton, Ph.D. |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Jeffrey A.
Bluestone, Ph.D. |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Sandra J.
Horning, M.D. |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Kelly A.
Kramer |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Kevin E.
Lofton |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Harish
Manwani |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Daniel P.
O'Day |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Javier J.
Rodriguez |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Anthony
Welters |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the selection of Ernst
& Young LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, on an advisory basis,
the compensation of our Named Executive Officers as presented in
the Proxy Statement. |
|
Management |
|
For |
|
For |
|
4. |
|
To approve the Gilead Sciences,
Inc. 2022 Equity Incentive Plan. |
|
Management |
|
For |
|
For |
|
5. |
|
To vote on a stockholder proposal,
if properly presented at the meeting, requesting that the Board
adopt a policy that the Chairperson of the Board of Directors be an
independent director. |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
To vote on a stockholder proposal,
if properly presented at the meeting, requesting that the Board
include one member from Gilead's non-management employees. |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
To vote on a stockholder proposal,
if properly presented at the meeting, requesting a 10% threshold to
call a special stockholder meeting. |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
To vote on a stockholder proposal,
if properly presented at the meeting, requesting that the Board
publish a third- party review of Gilead's lobbying activities. |
|
Shareholder |
|
Against |
|
For |
|
9. |
|
To vote on a stockholder proposal,
if properly presented at the meeting, requesting a Board report on
oversight of risks related to anticompetitive practices. |
|
Shareholder |
|
Against |
|
For |
|
GLOBAL MEDICAL REIT, INC.
Security |
37954A204 |
Meeting Type |
Annual |
Ticker Symbol |
GMRE |
Meeting Date |
11-May-2022 |
Record Date |
15-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election of Director to serve until
next annual meeting: Jeffrey M. Busch |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director to serve until
next annual meeting: Matthew Cypher |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director to serve until
next annual meeting: Ronald Marston |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election of Director to serve until
next annual meeting: Roscoe Moore, Jr. |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election of Director to serve until
next annual meeting: Henry E. Cole |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election of Director to serve until
next annual meeting: Zhang Huiqi |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election of Director to serve until
next annual meeting: Paula R. Crowley |
|
Management |
|
For |
|
For |
|
1.8 |
|
Election of Director to serve until
next annual meeting: Lori Wittman |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory vote to approve the
compensation of the Company's named executive officers as described
in the accompanying Proxy Statement. |
|
Management |
|
For |
|
For |
|
3. |
|
To ratify the appointment of
Deloitte & Touche LLP as the Company's independent registered
public accounting firm for the year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
Security |
40131M109 |
Meeting Type |
Annual |
Ticker Symbol |
GH |
Meeting Date |
15-Jun-2022 |
Record Date |
18-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Class I Director:
Vijaya Gadde |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Class I Director:
Myrtle Potter |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of
Ernst & Young LLP as Guardant Health, Inc.'s independent
registered public accounting firm for the year ending December 31,
2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Non-binding advisory vote to
approve Guardant Health, Inc.'s named executive officer
compensation. |
|
Management |
|
For |
|
For |
|
Security |
40412C101 |
Meeting Type |
Annual |
Ticker Symbol |
HCA |
Meeting Date |
21-Apr-2022 |
Record Date |
25-Feb-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election of Director: Thomas F.
Frist III |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Samuel N.
Hazen |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Meg G.
Crofton |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Robert J.
Dennis |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Nancy-Ann
DeParle |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: William R.
Frist |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Charles O.
Holliday, Jr. |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Hugh F.
Johnston |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Michael W.
Michelson |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: Wayne J.
Riley, M.D. |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director: Andrea B.
Smith |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the appointment of Ernst
& Young LLP as our independent registered public accounting
firm for the year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve named
executive officer compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Stockholder proposal, if properly
presented at the meeting, regarding political spending
disclosure. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Stockholder proposal, if properly
presented at the meeting, regarding lobbying disclosure. |
|
Shareholder |
|
Against |
|
For |
|
HEALTHCARE REALTY TRUST
INCORPORATED |
Security |
421946104 |
Meeting Type |
Annual |
Ticker Symbol |
HR |
Meeting Date |
10-May-2022 |
Record Date |
16-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
Todd J. Meredith |
|
|
|
For |
|
For |
|
|
|
2. |
John V. Abbott |
|
|
|
For |
|
For |
|
|
|
3. |
Nancy H. Agee |
|
|
|
For |
|
For |
|
|
|
4. |
Edward H. Braman |
|
|
|
For |
|
For |
|
|
|
5. |
Ajay Gupta |
|
|
|
For |
|
For |
|
|
|
6. |
James J. Kilroy |
|
|
|
For |
|
For |
|
|
|
7. |
Peter F. Lyle, Sr. |
|
|
|
For |
|
For |
|
|
|
8. |
John Knox Singleton |
|
|
|
For |
|
For |
|
|
|
9. |
Christann M. Vasquez |
|
|
|
For |
|
For |
|
2. |
|
To ratify the
appointment of BDO USA, LLP as the independent registered public
accounting firm for the Company and its subsidiaries for the
Company's 2022 fiscal year. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, on a
non-binding advisory basis, the following resolution: RESOLVED,
that the shareholders of Healthcare Realty Trust Incorporated
approve, on a non-binding advisory basis, the compensation of the
Named Executive Officers as disclosed pursuant to Item 402 of
Regulation S-K in the Company's proxy statement for the 2022 Annual
Meeting of Shareholders. |
|
Management |
|
For |
|
For |
|
HEALTHCARE REALTY TRUST
INCORPORATED |
Security |
421946104 |
Meeting Type |
Special |
Ticker Symbol |
HR |
Meeting Date |
15-Jul-2022 |
Record Date |
10-Jun-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
To approve the merger of HR
Acquisition 2, LLC, a Maryland limited liability company and a
direct, wholly- owned subsidiary of Healthcare Trust of America,
Inc., a Maryland corporation (the "Company"), with and into
Healthcare Realty Trust Incorporated, a Maryland Corporation
("HR"),with HR continuing as the surviving entity and a direct,
wholly-owned subsidiary of the Company, pursuant to which each
outstanding share of HR common stock will be exchanged for one
newly- issued share of the Company's class A common stock. |
|
Management |
|
For |
|
For |
|
2. |
|
To approve the adjournment of the
special meeting, if necessary or appropriate, including to solicit
additional proxies in favor of Proposal 1 if there are insufficient
votes at the time of such adjournment to approve Proposal 1. |
|
Management |
|
For |
|
For |
|
Security |
42226A107 |
Meeting Type |
Annual |
Ticker Symbol |
HQY |
Meeting Date |
23-Jun-2022 |
Record Date |
29-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1a. |
|
Robert Selander |
|
Management |
|
For |
|
For |
|
1b. |
|
Jon Kessler |
|
Management |
|
For |
|
For |
|
1c. |
|
Stephen Neeleman, M.D. |
|
Management |
|
For |
|
For |
|
1d. |
|
Frank Corvino |
|
Management |
|
For |
|
For |
|
1e. |
|
Adrian Dillon |
|
Management |
|
For |
|
For |
|
1f. |
|
Evelyn Dilsaver |
|
Management |
|
For |
|
For |
|
1g. |
|
Debra McCowan |
|
Management |
|
For |
|
For |
|
1h. |
|
Rajesh Natarajan |
|
Management |
|
For |
|
For |
|
1i. |
|
Stuart Parker |
|
Management |
|
For |
|
For |
|
1j. |
|
Ian Sacks |
|
Management |
|
For |
|
For |
|
1k. |
|
Gayle Wellborn |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the appointment of
PricewaterhouseCoopers LLP as our independent registered public
accounting firm for our fiscal year ending January 31, 2023. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, on a non-binding,
advisory basis, the fiscal 2022 compensation paid to our named
executive officers. |
|
Management |
|
For |
|
For |
|
HEALTHPEAK PROPERTIES, INC.
Security |
42250P103 |
Meeting
Type |
Annual |
Ticker
Symbol |
PEAK |
Meeting
Date |
28-Apr-2022 |
Record
Date |
01-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Brian G. Cartwright |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Christine N. Garvey |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: R. Kent Griffin, Jr. |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: David B. Henry |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Thomas M. Herzog |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Lydia H. Kennard |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Sara G. Lewis |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Katherine M. Sandstrom |
|
Management |
|
For |
|
For |
|
2. |
|
Approval
of 2021 executive compensation on an advisory basis. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification
of the appointment of Deloitte & Touche LLP as Healthpeak
Properties, Inc.'s independent registered public accounting firm
for the year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
Security |
436440101 |
Meeting
Type |
Annual |
Ticker
Symbol |
HOLX |
Meeting
Date |
10-Mar-2022 |
Record
Date |
11-Jan-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Stephen P. MacMillan |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Sally W. Crawford |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Charles J. Dockendorff |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Scott T. Garrett |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Ludwig N. Hantson |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Namal Nawana |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Christiana Stamoulis |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Amy M. Wendell |
|
Management |
|
For |
|
For |
|
2. |
|
A
non-binding advisory resolution to approve executive
compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification
of the appointment of Ernst & Young LLP as our independent
registered public accounting firm for fiscal 2022. |
|
Management |
|
For |
|
For |
|
Security |
G46188101 |
Meeting
Type |
Annual |
Ticker
Symbol |
HZNP |
Meeting
Date |
28-Apr-2022 |
Record
Date |
24-Feb-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Class II Director: Michael Grey |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Class II Director: Jeff Himawan, Ph.D. |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Class II Director: Susan Mahony, Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
Approval
of the appointment of PricewaterhouseCoopers LLP as our independent
registered public accounting firm for our fiscal year ending
December 31, 2022 and authorization of the Audit Committee to
determine the auditors' remuneration. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval,
on an advisory basis, of the compensation of our named executive
officers, as disclosed in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
4. |
|
Authorization
for us and/or any of our subsidiaries to make market purchases or
overseas market purchases of our ordinary shares. |
|
Management |
|
For |
|
For |
|
5. |
|
Approval
of the Amended and Restated 2020 Equity Incentive Plan. |
|
Management |
|
For |
|
For |
|
Security |
444859102 |
Meeting
Type |
Annual |
Ticker
Symbol |
HUM |
Meeting
Date |
21-Apr-2022 |
Record
Date |
28-Feb-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A) |
|
Election
of Director: Raquel C. Bono, M.D. |
|
Management |
|
For |
|
For |
|
1B) |
|
Election
of Director: Bruce D. Broussard |
|
Management |
|
For |
|
For |
|
1C) |
|
Election
of Director: Frank A. D'Amelio |
|
Management |
|
For |
|
For |
|
1D) |
|
Election
of Director: David T. Feinberg, M.D. |
|
Management |
|
For |
|
For |
|
1E) |
|
Election
of Director: Wayne A. I. Frederick, M.D. |
|
Management |
|
For |
|
For |
|
1F) |
|
Election
of Director: John W. Garratt |
|
Management |
|
For |
|
For |
|
1G) |
|
Election
of Director: Kurt J. Hilzinger |
|
Management |
|
For |
|
For |
|
1H) |
|
Election
of Director: David A. Jones, Jr. |
|
Management |
|
For |
|
For |
|
1I) |
|
Election
of Director: Karen W. Katz |
|
Management |
|
For |
|
For |
|
1J) |
|
Election
of Director: Marcy S. Klevorn |
|
Management |
|
For |
|
For |
|
1K) |
|
Election
of Director: William J. McDonald |
|
Management |
|
For |
|
For |
|
1L) |
|
Election
of Director: Jorge S. Mesquita |
|
Management |
|
For |
|
For |
|
1M) |
|
Election
of Director: James J. O'Brien |
|
Management |
|
For |
|
For |
|
2) |
|
The
ratification of the appointment of PricewaterhouseCoopers LLP as
the Company's independent registered public accounting
firm. |
|
Management |
|
For |
|
For |
|
3) |
|
Non-binding
advisory vote for the approval of the compensation of the named
executive officers as disclosed in the 2022 proxy
statement. |
|
Management |
|
For |
|
For |
|
Security |
45168D104 |
Meeting
Type |
Annual |
Ticker
Symbol |
IDXX |
Meeting
Date |
11-May-2022 |
Record
Date |
14-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director (Proposal One): Jonathan W. Ayers |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director (Proposal One): Stuart M. Essig, PhD |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director (Proposal One): Jonathan J. Mazelsky |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director (Proposal One): M. Anne Szostak |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of Appointment of Independent Registered Public Accounting Firm. To
ratify the selection of PricewaterhouseCoopers LLP as the Company's
independent registered public accounting firm for the current
fiscal year (Proposal Two). |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
Vote on Executive Compensation. To approve a nonbinding advisory
resolution on the Company's executive compensation (Proposal
Three). |
|
Management |
|
For |
|
For |
|
Security |
452327109 |
Meeting
Type |
Annual |
Ticker
Symbol |
ILMN |
Meeting
Date |
26-May-2022 |
Record
Date |
31-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Frances Arnold, Ph.D. |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Francis A. deSouza |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Caroline D. Dorsa |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Robert S. Epstein, M.D. |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Scott Gottlieb, M.D. |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Gary S. Guthart, Ph.D. |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Philip W. Schiller |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Susan E. Siegel |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: John W. Thompson |
|
Management |
|
For |
|
For |
|
2. |
|
To
ratify the appointment of Ernst & Young LLP as our independent
registered public accounting firm for the fiscal year ending
January 1, 2023. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve, on an advisory basis, the compensation of the named
executive officers as disclosed in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
4. |
|
To
approve, on an advisory basis, a stockholder proposal regarding the
right of stockholders to call special meetings. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
To
approve an amendment to our Amended and Restated Certificate of
Incorporation to permit stockholders to call special
meetings. |
|
Management |
|
For |
|
For |
|
Security |
46120E602 |
Meeting
Type |
Special |
Ticker
Symbol |
ISRG |
Meeting
Date |
20-Sep-2021 |
Record
Date |
18-Aug-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
TO
APPROVE THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON
STOCK FOR THE PURPOSE OF EFFECTING A THREE-FOR-ONE STOCK
SPLIT. |
|
Management |
|
For |
|
For |
|
Security |
46120E602 |
Meeting
Type |
Annual |
Ticker
Symbol |
ISRG |
Meeting
Date |
28-Apr-2022 |
Record
Date |
01-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Craig H. Barratt, Ph.D. |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Joseph C. Beery |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Gary S. Guthart, Ph.D. |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Amal M. Johnson |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Don R. Kania, Ph.D. |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Amy L. Ladd, M.D. |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Keith R. Leonard, Jr. |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Alan J. Levy, Ph.D. |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Jami Dover Nachtsheim |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: Monica P. Reed, M.D. |
|
Management |
|
For |
|
For |
|
1K. |
|
Election
of Director: Mark J. Rubash |
|
Management |
|
For |
|
For |
|
2. |
|
To
approve, by advisory vote, the compensation of the Company's Named
Executive Officers. |
|
Management |
|
For |
|
For |
|
3. |
|
The
ratification of appointment of PricewaterhouseCoopers LLP as the
Company's independent registered public accounting firm for the
fiscal year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
4. |
|
To
approve the Company's Amended and Restated 2010 Incentive Award
Plan. |
|
Management |
|
For |
|
For |
|
Security |
46266C105 |
Meeting
Type |
Annual |
Ticker
Symbol |
IQV |
Meeting
Date |
12-Apr-2022 |
Record
Date |
15-Feb-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
John
P. Connaughton |
|
|
|
For |
|
For |
|
|
|
2. |
John
G. Danhakl |
|
|
|
For |
|
For |
|
|
|
3. |
James
A. Fasano |
|
|
|
For |
|
For |
|
|
|
4. |
Leslie
Wims Morris |
|
|
|
For |
|
For |
|
2. |
|
Amendment
to Certificate of Incorporation to declassify the Board of
Directors over time and provide for the annual election of all
directors. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
(non-binding) vote to approve executive compensation
(say-on-pay). |
|
Management |
|
For |
|
For |
|
4. |
|
If
properly presented, a shareholder proposal regarding majority
voting in uncontested director elections. |
|
Management |
|
Against |
|
For |
|
5. |
|
The
ratification of the appointment of PricewaterhouseCoopers LLP as
IQVIA Holdings Inc.'s independent registered public accounting firm
for the year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
Security |
478160104 |
Meeting
Type |
Annual |
Ticker
Symbol |
JNJ |
Meeting
Date |
28-Apr-2022 |
Record
Date |
01-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Darius Adamczyk |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Mary C. Beckerle |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: D. Scott Davis |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Ian E. L. Davis |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Jennifer A. Doudna |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Joaquin Duato |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Alex Gorsky |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Marillyn A. Hewson |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Hubert Joly |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: Mark B. McClellan |
|
Management |
|
For |
|
For |
|
1K. |
|
Election
of Director: Anne M. Mulcahy |
|
Management |
|
For |
|
For |
|
1L. |
|
Election
of Director: A. Eugene Washington |
|
Management |
|
For |
|
For |
|
1M. |
|
Election
of Director: Mark A. Weinberger |
|
Management |
|
For |
|
For |
|
1N. |
|
Election
of Director: Nadja Y. West |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory
Vote to Approve Named Executive Officer Compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval
of the Company's 2022 Long-Term Incentive Plan. |
|
Management |
|
For |
|
For |
|
4. |
|
Ratification
of Appointment of PricewaterhouseCoopers LLP as the Independent
Registered Public Accounting Firm for 2022. |
|
Management |
|
For |
|
For |
|
5. |
|
Proposal
Withdrawn (Federal Securities Laws Mandatory Arbitration
Bylaw). |
|
Shareholder |
|
Against |
|
|
|
6. |
|
Civil
Rights, Equity, Diversity & Inclusion Audit
Proposal. |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Third
Party Racial Justice Audit. |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
Report
on Government Financial Support and Access to COVID-19 Vaccines and
Therapeutics. |
|
Shareholder |
|
Against |
|
For |
|
9. |
|
Report
on Public Health Costs of Protecting Vaccine
Technology. |
|
Shareholder |
|
Against |
|
For |
|
10. |
|
Discontinue
Global Sales of Baby Powder Containing Talc. |
|
Shareholder |
|
Against |
|
For |
|
11. |
|
Request
for Charitable Donations Disclosure. |
|
Shareholder |
|
Against |
|
For |
|
12. |
|
Third
Party Review and Report on Lobbying Activities Alignment with
Position on Universal Health Coverage. |
|
Shareholder |
|
Against |
|
For |
|
13. |
|
Adopt
Policy to Include Legal and Compliance Costs in Incentive
Compensation Metrics. |
|
Shareholder |
|
Against |
|
For |
|
14. |
|
CEO
Compensation to Weigh Workforce Pay and Ownership. |
|
Shareholder |
|
Against |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
LABORATORY
CORP. OF AMERICA HOLDINGS |
Security |
50540R409 |
Meeting
Type |
Annual |
Ticker
Symbol |
LH |
Meeting
Date |
11-May-2022 |
Record
Date |
16-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Kerrii B. Anderson |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Jean-Luc Bélingard |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Jeffrey A. Davis |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: D. Gary Gilliland, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Garheng Kong, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Peter M. Neupert |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Richelle P. Parham |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Adam H. Schechter |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Kathryn E. Wengel |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: R. Sanders Williams, M.D. |
|
Management |
|
For |
|
For |
|
2. |
|
To
approve, by non-binding vote, executive compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification
of the appointment of Deloitte and Touche LLP as Laboratory
Corporation of America Holdings' independent registered public
accounting firm for the year ending December 31,
2022. |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder
proposal seeking an amendment to our governing documents relating
to procedural requirements in connection with shareholders' rights
to call a special meeting. |
|
Shareholder |
|
Against |
|
For |
|
Security |
502175102 |
Meeting
Type |
Annual |
Ticker
Symbol |
LTC |
Meeting
Date |
25-May-2022 |
Record
Date |
11-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Cornelia
Cheng |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Boyd W.
Hendrickson |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director to hold office until the 2023 Annual Meeting: James J.
Pieczynski |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Devra G.
Shapiro |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Wendy L.
Simpson |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Timothy
J. Triche |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
Security |
58155Q103 |
Meeting
Type |
Annual |
Ticker
Symbol |
MCK |
Meeting
Date |
23-Jul-2021 |
Record
Date |
28-May-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director for a one-year term: Dominic J. Caruso |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director for a one-year term: Donald R. Knauss |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director for a one-year term: Bradley E. Lerman |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director for a one-year term: Linda P. Mantia |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director for a one-year term: Maria Martinez |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director for a one-year term: Edward A. Mueller |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director for a one-year term: Susan R. Salka |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director for a one-year term: Brian S. Tyler |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director for a one-year term: Kenneth E. Washington |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of the appointment of Deloitte & Touche LLP as the
company's independent registered public accounting firm for the
fiscal year ending March 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
vote on executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder
proposal on action by written consent of shareholders. |
|
Shareholder |
|
Against |
|
For |
|
MEDICAL
PROPERTIES TRUST, INC. |
Security |
58463J304 |
Meeting
Type |
Annual |
Ticker
Symbol |
MPW |
Meeting
Date |
26-May-2022 |
Record
Date |
29-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Director: Edward K. Aldag, Jr. |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Director: G. Steven Dawson |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Director: R. Steven Hamner |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election
of Director: Caterina A. Mozingo |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election
of Director: Emily W. Murphy |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election
of Director: Elizabeth N. Pitman |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election
of Director: D. Paul Sparks, Jr. |
|
Management |
|
For |
|
For |
|
1.8 |
|
Election
of Director: Michael G. Stewart |
|
Management |
|
For |
|
For |
|
1.9 |
|
Election
of Director: C. Reynolds Thompson, III |
|
Management |
|
For |
|
For |
|
2. |
|
To
ratify the appointment of PricewaterhouseCoopers LLP as independent
registered public accounting firm for the fiscal year ending
December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve the compensation of the Company's executive officers, on a
non-binding basis. |
|
Management |
|
For |
|
For |
|
4. |
|
To
approve the Medical Properties Trust, Inc. Amended and
Restated 2019 Equity Investment Plan. |
|
Management |
|
For |
|
For |
|
Security |
G5960L103 |
Meeting
Type |
Annual |
Ticker
Symbol |
MDT |
Meeting
Date |
09-Dec-2021 |
Record
Date |
14-Oct-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director until the 2022 Annual General Meeting: Richard H.
Anderson |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director until the 2022 Annual General Meeting: Craig
Arnold |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director until the 2022 Annual General Meeting: Scott C.
Donnelly |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director until the 2022 Annual General Meeting: Andrea J.
Goldsmith, Ph.D. |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director until the 2022 Annual General Meeting: Randall J.
Hogan, III |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director until the 2022 Annual General Meeting: Kevin E.
Lofton |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director until the 2022 Annual General Meeting: Geoffrey S.
Martha |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director until the 2022 Annual General Meeting: Elizabeth G.
Nabel, M.D. |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director until the 2022 Annual General Meeting: Denise M.
O'Leary |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director until the 2022 Annual General Meeting: Kendall J.
Powell |
|
Management |
|
For |
|
For |
|
2. |
|
Ratifying,
in a non-binding vote, the appointment of PricewaterhouseCoopers
LLP as the Company's independent auditor for fiscal year 2022 and
authorizing, in a binding vote, the Board of Directors, acting
through the Audit Committee, to set the auditor's
remuneration. |
|
Management |
|
For |
|
For |
|
3. |
|
Approving,
on an advisory basis, the Company's executive
compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Approving,
on an advisory basis, the frequency of Say- on-Pay
votes. |
|
Management |
|
1
Year |
|
For |
|
5. |
|
Approving
the new 2021 Medtronic plc Long Term Incentive Plan. |
|
Management |
|
For |
|
For |
|
6. |
|
Renewing
the Board of Directors' authority to issue shares under Irish
law. |
|
Management |
|
For |
|
For |
|
7. |
|
Renewing
the Board of Directors' authority to opt out of pre- emption rights
under Irish law. |
|
Management |
|
For |
|
For |
|
8. |
|
Authorizing
the Company and any subsidiary of the Company to make overseas
market purchases of Medtronic ordinary shares. |
|
Management |
|
For |
|
For |
|
Security |
58933Y105 |
Meeting
Type |
Annual |
Ticker
Symbol |
MRK |
Meeting
Date |
24-May-2022 |
Record
Date |
25-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Douglas M. Baker, Jr. |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Mary Ellen Coe |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Pamela J. Craig |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Robert M. Davis |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Kenneth C. Frazier |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Thomas H. Glocer |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Risa J. Lavizzo-Mourey, M.D. |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Stephen L. Mayo, Ph.D. |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Paul B. Rothman, M.D. |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: Patricia F. Russo |
|
Management |
|
For |
|
For |
|
1K. |
|
Election
of Director: Christine E. Seidman, M.D. |
|
Management |
|
For |
|
For |
|
1L. |
|
Election
of Director: Inge G. Thulin |
|
Management |
|
For |
|
For |
|
1M. |
|
Election
of Director: Kathy J. Warden |
|
Management |
|
For |
|
For |
|
1N. |
|
Election
of Director: Peter C. Wendell |
|
Management |
|
For |
|
For |
|
2. |
|
Non-binding
advisory vote to approve the compensation of our named executive
officers. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification
of the appointment of the Company's independent registered public
accounting firm for 2022. |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder
proposal regarding an independent board chairman. |
|
Shareholder |
|
For |
|
Against |
|
5. |
|
Shareholder
proposal regarding access to COVID-19 products. |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
Shareholder
proposal regarding lobbying expenditure disclosure. |
|
Shareholder |
|
Against |
|
For |
|
METTLER-TOLEDO
INTERNATIONAL, INC. |
Security |
592688105 |
Meeting
Type |
Annual |
Ticker
Symbol |
MTD |
Meeting
Date |
05-May-2022 |
Record
Date |
07-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Director: Robert F. Spoerry |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Director: Wah-Hui Chu |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Director: Domitille Doat-Le Bigot |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election
of Director: Olivier A. Filliol |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election
of Director: Elisha W. Finney |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election
of Director: Richard Francis |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election
of Director: Michael A. Kelly |
|
Management |
|
For |
|
For |
|
1.8 |
|
Election
of Director: Thomas P. Salice |
|
Management |
|
For |
|
For |
|
2. |
|
RATIFICATION
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. |
|
Management |
|
For |
|
For |
|
3. |
|
ADVISORY
VOTE TO APPROVE EXECUTIVE COMPENSATION. |
|
Management |
|
For |
|
For |
|
Security |
60770K107 |
Meeting
Type |
Annual |
Ticker
Symbol |
MRNA |
Meeting
Date |
28-Apr-2022 |
Record
Date |
01-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1 |
Noubar
Afeyan, Ph.D. |
|
|
|
For |
|
For |
|
|
|
2 |
Stéphane
Bancel |
|
|
|
For |
|
For |
|
|
|
3 |
François
Nader, M.D. |
|
|
|
For |
|
For |
|
2. |
|
To
approve, on a non-binding, advisory basis, the compensation of our
named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To
ratify the appointment of Ernst & Young LLP as our
registered independent public accounting firm for the year ending
December 31, 2022. |
|
Management |
|
For |
|
For |
|
4. |
|
To
vote on a shareholder proposal relating to the feasibility of
transferring intellectual property. |
|
Shareholder |
|
For |
|
Against |
|
Security |
60855R100 |
Meeting
Type |
Annual |
Ticker
Symbol |
MOH |
Meeting
Date |
04-May-2022 |
Record
Date |
07-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Barbara
L. Brasier |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Daniel
Cooperman |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Stephen
H. Lockhart |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Steven J.
Orlando |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Ronna E.
Romney |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Richard
M. Schapiro |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Dale B.
Wolf |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Richard
C. Zoretic |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director to hold office until the 2023 Annual Meeting: Joseph M.
Zubretsky |
|
Management |
|
For |
|
For |
|
2. |
|
To
consider and approve, on a non-binding, advisory basis, the
compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To
ratify the appointment of Ernst & Young LLP as our
independent registered public accounting firm for 2022. |
|
Management |
|
For |
|
For |
|
NATIONAL
HEALTH INVESTORS, INC. |
Security |
63633D104 |
Meeting
Type |
Annual |
Ticker
Symbol |
NHI |
Meeting
Date |
06-May-2022 |
Record
Date |
11-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: James R. Jobe |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Robert G. Adams |
|
Management |
|
For |
|
For |
|
2. |
|
Approve
the advisory resolution approving the compensation of the named
executive officers as disclosed in the accompanying Proxy
Statement. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratify
the audit committee's selection of BDO USA, LLP as independent
registered public accounting firm for the year ending
December 31, 2022. |
|
Management |
|
For |
|
For |
|
NEW
SENIOR INVESTMENT GROUP, INC. |
Security |
648691103 |
Meeting
Type |
Special |
Ticker
Symbol |
SNR |
Meeting
Date |
14-Sep-2021 |
Record
Date |
06-Aug-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
Adopt
the Agreement and Plan of Merger, dated as of June 28, 2021
(as amended or otherwise modified from time to time, the "Merger
Agreement"), by and among New Senior Investment Group Inc., a
Delaware corporation ("New Senior"), Ventas, Inc., a Delaware
corporation ("Ventas"), and Cadence Merger Sub LLC, a Delaware
limited liability company and a subsidiary of Ventas, Inc.
("Merger Sub"), and thereby approve the merger of Merger Sub with
and into New Senior, with New Senior continuing as the surviving
corporation and a subsidiary of Ventas. |
|
Management |
|
For |
|
For |
|
2. |
|
Approve,
by advisory (non-binding) vote, the compensation that may be paid
or become payable to the named executive officers of New Senior in
connection with transactions contemplated by the Merger
Agreement. |
|
Management |
|
For |
|
For |
|
3. |
|
Approve
the adjournment of the special meeting of the New Senior
stockholders (the "Special Meeting") from time to time, if
necessary or appropriate, (i) to solicit additional proxies in
favor of the proposal to adopt the Merger Agreement if there are
insufficient votes at the time of such adjournment to approve such
proposal or (ii) if required to enable New Senior or Ventas to
comply with the requirement in the Merger Agreement to provide
notice to the other party 10 business days prior to the Special
Meeting |
|
Management |
|
For |
|
For |
|
Security |
N/A |
Meeting
Type |
Written
Consent |
Ticker
Symbol |
N/A |
Meeting
Date |
27-Apr-2022 |
Record
Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
Approval
of the Financial Statements 2021. |
|
Management |
|
For |
|
For |
|
2. |
|
Appropriation
of Balance Sheet Results 2021. |
|
Management |
|
For |
|
For |
|
3. |
|
Discharge
of the Members of the Board and Management. |
|
Management |
|
For |
|
For |
|
4. |
|
Re-Election
of the Board of Directors: |
|
|
|
|
|
|
|
4.1 |
|
Mr. Anthony
(Tony) Rosenberg |
|
Management |
|
For |
|
For |
|
4.2 |
|
Dr. Riad
Sherif |
|
Management |
|
For |
|
For |
|
4.3 |
|
Mr. Àrni
Audunn Blöndal |
|
Management |
|
For |
|
For |
|
4.4 |
|
Mr. Lionel
Carnot |
|
Management |
|
For |
|
For |
|
4.5 |
|
Mr. Bartosz
Dzikowski |
|
Management |
|
For |
|
For |
|
4.6 |
|
Dr. Xin
(Sylvia) He |
|
Management |
|
For |
|
For |
|
4.7 |
|
Dr. Robert
Lorne Hopfner |
|
Management |
|
For |
|
For |
|
4.8 |
|
Ms. Yi
Fei (Vanessa) Huang |
|
Management |
|
For |
|
For |
|
4.9 |
|
Dr. Henry
Skinner |
|
Management |
|
For |
|
For |
|
5. |
|
Re-Election
of the Auditors PricewaterhouseCoopers SA. |
|
Management |
|
For |
|
For |
|
Security |
N/A |
Meeting
Type |
Extraordinary
General Meeting |
Ticker
Symbol |
N/A |
Meeting
Date |
30-Nov-2021 |
Record
Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
Ordinary
share capital increase |
|
Management |
|
For |
|
For |
|
2. |
|
Conditional
capital share increase |
|
Management |
|
For |
|
For |
|
OMEGA
HEALTHCARE INVESTORS, INC. |
Security |
681936100 |
Meeting
Type |
Annual |
Ticker
Symbol |
OHI |
Meeting
Date |
03-Jun-2022 |
Record
Date |
06-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Kapila K. Anand |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Craig R. Callen |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Dr. Lisa C. Egbuonu-Davis |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Barbara B. Hill |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Kevin J. Jacobs |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: C. Taylor Pickett |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Stephen D. Plavin |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Burke W. Whitman |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of Independent Auditors Ernst & Young LLP for fiscal year
2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval,
on an Advisory Basis, of Executive Compensation. |
|
Management |
|
For |
|
For |
|
Security |
690732102 |
Meeting
Type |
Annual |
Ticker
Symbol |
OMI |
Meeting
Date |
29-Apr-2022 |
Record
Date |
04-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Director: Mark A. Beck |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Director: Gwendolyn M. Bingham |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Director: Kenneth Gardner-Smith |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election
of Director: Robert J. Henkel |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election
of Director: Stephen W. Klemash |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election
of Director: Mark F. McGettrick |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election
of Director: Edward A. Pesicka |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of the appointment of KPMG LLP as the Company's independent public
accounting firm for the year ending December 31,
2022 |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
vote to approve the compensation of the Company's named executive
officers |
|
Management |
|
For |
|
For |
|
4. |
|
Advisory
vote on the frequency of a shareholder vote on the compensation of
the Company's named executive officers |
|
Management |
|
1
Year |
|
For |
|
Security |
714046109 |
Meeting
Type |
Annual |
Ticker
Symbol |
PKI |
Meeting
Date |
26-Apr-2022 |
Record
Date |
28-Feb-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director for a term of one year: Peter Barrett, PhD |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director for a term of one year: Samuel R. Chapin |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director for a term of one year: Sylvie Grégoire,
PharmD |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director for a term of one year: Alexis P. Michas |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director for a term of one year: Prahlad R. Singh,
PhD |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director for a term of one year: Michel Vounatsos |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director for a term of one year: Frank Witney, PhD |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director for a term of one year: Pascale Witz |
|
Management |
|
For |
|
For |
|
2. |
|
To
ratify the selection of Deloitte & Touche LLP as
PerkinElmer's independent registered public accounting firm for the
current fiscal year. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve, by non-binding advisory vote, our executive
compensation. |
|
Management |
|
For |
|
For |
|
Security |
G97822103 |
Meeting
Type |
Annual |
Ticker
Symbol |
PRGO |
Meeting
Date |
06-May-2022 |
Record
Date |
07-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Bradley A. Alford |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Orlando D. Ashford |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Katherine C. Doyle |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Adriana Karaboutis |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Murray S. Kessler |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Jeffrey B. Kindler |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Erica L. Mann |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Donal O'Connor |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Geoffrey M. Parker |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director to hold office until the 2023 Annual General Meeting of
Shareholders: Theodore R. Samuels |
|
Management |
|
For |
|
For |
|
2. |
|
Ratify,
in a non-binding advisory vote, the appointment of Ernst &
Young LLP as the Company's independent auditor, and authorize, in a
binding vote, the Board of Directors, acting through the Audit
Committee, to fix the remuneration of the auditor |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory
vote on executive compensation |
|
Management |
|
For |
|
For |
|
4. |
|
Amend
the Company's Long-Term Incentive Plan |
|
Management |
|
For |
|
For |
|
5. |
|
Renew
the Board's authority to issue shares under Irish law |
|
Management |
|
For |
|
For |
|
6. |
|
Renew
the Board's authority to opt-out of statutory pre- emption rights
under Irish law |
|
Management |
|
For |
|
For |
|
Security |
717081103 |
Meeting
Type |
Annual |
Ticker
Symbol |
PFE |
Meeting
Date |
28-Apr-2022 |
Record
Date |
02-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Election
of Director: Ronald E. Blaylock |
|
Management |
|
For |
|
For |
|
1B. |
|
Election
of Director: Albert Bourla |
|
Management |
|
For |
|
For |
|
1C. |
|
Election
of Director: Susan Desmond-Hellmann |
|
Management |
|
For |
|
For |
|
1D. |
|
Election
of Director: Joseph J. Echevarria |
|
Management |
|
For |
|
For |
|
1E. |
|
Election
of Director: Scott Gottlieb |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director: Helen H. Hobbs |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director: Susan Hockfield |
|
Management |
|
For |
|
For |
|
1H. |
|
Election
of Director: Dan R. Littman |
|
Management |
|
For |
|
For |
|
1I. |
|
Election
of Director: Shantanu Narayen |
|
Management |
|
For |
|
For |
|
1J. |
|
Election
of Director: Suzanne Nora Johnson |
|
Management |
|
For |
|
For |
|
1K. |
|
Election
of Director: James Quincey |
|
Management |
|
For |
|
For |
|
1L. |
|
Election
of Director: James C. Smith |
|
Management |
|
For |
|
For |
|
2. |
|
Ratify
the selection of KPMG LLP as independent registered public
accounting firm for 2022 |
|
Management |
|
For |
|
For |
|
3. |
|
2022
advisory approval of executive compensation |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder
proposal regarding amending proxy access |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Shareholder
proposal regarding report on political expenditures
congruency |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
Shareholder
proposal regarding report on transfer of intellectual property to
potential COVID-19 manufacturers |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Shareholder
proposal regarding report on board oversight of risks related to
anticompetitive practices |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
Shareholder
proposal regarding report on public health costs of protecting
vaccine technology |
|
Shareholder |
|
Against |
|
For |
|
Security |
71943U104 |
Meeting
Type |
Annual |
Ticker
Symbol |
DOC |
Meeting
Date |
03-May-2022 |
Record
Date |
24-Feb-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Trustee: John T. Thomas |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Trustee: Tommy G. Thompson |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Trustee: Stanton D. Anderson |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election
of Trustee: Mark A. Baumgartner |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election
of Trustee: Albert C. Black, Jr. |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election
of Trustee: William A. Ebinger, M.D. |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election
of Trustee: Pamela J. Kessler |
|
Management |
|
For |
|
For |
|
1.8 |
|
Election
of Trustee: Ava E. Lias-Booker |
|
Management |
|
For |
|
For |
|
1.9 |
|
Election
of Trustee: Richard A. Weiss |
|
Management |
|
For |
|
For |
|
2. |
|
To
ratify the appointment of Ernst & Young LLP as the
Company's independent registered public accounting firm for the
fiscal year ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve, on a non-binding advisory basis, the compensation paid to
the Company's named executive officers. |
|
Management |
|
For |
|
For |
|
4. |
|
To
approve, on a non-binding advisory basis, the frequency of casting
future votes on the compensation paid to the Company's named
executive officers. |
|
Management |
|
1
Year |
|
For |
|
Security |
749397105 |
Meeting
Type |
Annual |
Ticker
Symbol |
RCM |
Meeting
Date |
26-May-2022 |
Record
Date |
06-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
|
|
1. |
Agnes
Bundy Scanlan |
|
|
|
For |
|
For |
|
|
|
2. |
David
M. Dill |
|
|
|
For |
|
For |
|
|
|
3. |
Michael
C. Feiner |
|
|
|
For |
|
For |
|
|
|
4. |
Joseph
Flanagan |
|
|
|
For |
|
For |
|
|
|
5. |
John
B. Henneman III |
|
|
|
For |
|
For |
|
|
|
6. |
Neal
Moszkowski |
|
|
|
For |
|
For |
|
|
|
7. |
Ian
Sacks |
|
|
|
For |
|
For |
|
|
|
8. |
Jill
Smith |
|
|
|
For |
|
For |
|
|
|
9. |
Anthony
J. Speranzo |
|
|
|
For |
|
For |
|
|
|
10. |
Anthony
R. Tersigni |
|
|
|
For |
|
For |
|
|
|
11. |
Albert
R. Zimmerli |
|
|
|
For |
|
For |
|
2. |
|
To
approve, for purposes of complying with the applicable provisions
of Nasdaq Listing Rule 5635, the issuance of shares of common
stock of Project Roadrunner Parent Inc. ("New R1") to CoyCo 1, L.P.
and CoyCo 2, L.P., pursuant to the terms of the Transaction
Agreement and Plan of Merger, dated as of January 9, 2022, by
and among the Company, New R1, Project Roadrunner Merger Sub Inc.,
Revint Holdings, LLC ("Cloudmed"), CoyCo 1, L.P., CoyCo 2., L.P.,
and certain other parties, as described in the accompanying proxy
statement/prospectus. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve the adoption of an amendment to the Company's Restated
Certificate of Incorporation to increase our authorized share
capital from 500,000,000 shares to 750,000,000 shares of common
stock. |
|
Management |
|
For |
|
For |
|
4. |
|
To
ratify the selection of Ernst & Young LLP as our
independent registered public accounting firm for the fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
5. |
|
To
approve the adjournment of the 2022 Annual Meeting to a later date,
or dates, if necessary, to permit further solicitation and vote of
proxies in the event that there are insufficient votes for the
approval of one or more proposals at the 2022 Annual
Meeting. |
|
Management |
|
For |
|
For |
|
Security |
75120L100 |
Meeting
Type |
Annual |
Ticker
Symbol |
RLYB |
Meeting
Date |
24-May-2022 |
Record
Date |
30-Mar-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Class I Director: Martin W. Mackay |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Class I Director: Kush M. Parmar |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Class I Director: Paula Soteropoulos |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of the appointment of Deloitte & Touche LLP as the
independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
REGENERON
PHARMACEUTICALS, INC. |
Security |
75886F107 |
Meeting
Type |
Annual |
Ticker
Symbol |
REGN |
Meeting
Date |
10-Jun-2022 |
Record
Date |
12-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1a. |
|
Election
of Director: Bonnie L. Bassler, Ph.D. |
|
Management |
|
For |
|
For |
|
1b. |
|
Election
of Director: Michael S. Brown, M.D. |
|
Management |
|
For |
|
For |
|
1c. |
|
Election
of Director: Leonard S. Schleifer, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
1d. |
|
Election
of Director: George D. Yancopoulos, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of the appointment of PricewaterhouseCoopers LLP as the Company's
independent registered public accounting firm for the fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Proposal
to approve, on an advisory basis, executive
compensation. |
|
Management |
|
For |
|
For |
|
Security |
761152107 |
Meeting
Type |
Annual |
Ticker
Symbol |
RMD |
Meeting
Date |
18-Nov-2021 |
Record
Date |
21-Sep-2021 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1A. |
|
Re-election
of Director to serve until 2022 annual meeting: Karen
Drexler |
|
Management |
|
For |
|
For |
|
1B. |
|
Re-election
of Director to serve until 2022 annual meeting: Michael
Farrell |
|
Management |
|
For |
|
For |
|
1C. |
|
Re-election
of Director to serve until 2022 annual meeting: Peter
Farrell |
|
Management |
|
For |
|
For |
|
1D. |
|
Re-election
of Director to serve until 2022 annual meeting: Harjit
Gill |
|
Management |
|
For |
|
For |
|
1E. |
|
Re-election
of Director to serve until 2022 annual meeting: Ron
Taylor |
|
Management |
|
For |
|
For |
|
1F. |
|
Election
of Director to serve until 2022 annual meeting: John
Hernandez |
|
Management |
|
For |
|
For |
|
1G. |
|
Election
of Director to serve until 2022 annual meeting: Desney
Tan |
|
Management |
|
For |
|
For |
|
2. |
|
Ratify
our selection of KPMG LLP as our independent registered public
accounting firm for the fiscal year ending June 30,
2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Approve,
on an advisory basis, the compensation paid to our named executive
officers, as disclosed in the proxy statement
("say-on-pay"). |
|
Management |
|
For |
|
For |
|
SABRA
HEALTH CARE REIT, INC. |
Security |
78573L106 |
Meeting
Type |
Annual |
Ticker
Symbol |
SBRA |
Meeting
Date |
14-Jun-2022 |
Record
Date |
18-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1a. |
|
Election
of Director: Craig A. Barbarosh |
|
Management |
|
For |
|
For |
|
1b. |
|
Election
of Director: Katie Cusack |
|
Management |
|
For |
|
For |
|
1c. |
|
Election
of Director: Michael J. Foster |
|
Management |
|
For |
|
For |
|
1d. |
|
Election
of Director: Lynne S. Katzmann |
|
Management |
|
For |
|
For |
|
1e. |
|
Election
of Director: Ann Kono |
|
Management |
|
For |
|
For |
|
1f. |
|
Election
of Director: Jeffrey A. Malehorn |
|
Management |
|
For |
|
For |
|
1g. |
|
Election
of Director: Richard K. Matros |
|
Management |
|
For |
|
For |
|
1h. |
|
Election
of Director: Clifton J. Porter II |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification
of the appointment of PricewaterhouseCoopers LLP as Sabra's
independent registered public accounting firm for the fiscal year
ending December 31, 2022. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval,
on an advisory basis, of the compensation of Sabra's named
executive officers. |
|
Management |
|
For |
|
For |
|
SAREPTA
THERAPEUTICS, INC. |
Security |
803607100 |
Meeting
Type |
Annual |
Ticker
Symbol |
SRPT |
Meeting
Date |
02-Jun-2022 |
Record
Date |
08-Apr-2022 |
|
|
Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
1.1 |
|
Election
of Class I Director to hold office until the 2024 Annual
meeting: Kathryn Boor, Ph.D. |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election
of Class I Director to hold office until the 2024 Annual
meeting: Michael Chambers |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election
of Class I Director to hold office until the 2024 Annual
meeting: Douglas S. Ingram |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election
of Class I Director to hold office until the 2024 Annual
meeting: Hans Wigzell, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
To
hold an advisory vote to approve, on a non-binding basis, named
executive officer compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
To
approve an amendment to the Company's 2018 Equity Incentive Plan
(the "2018 Plan") to increase the maximum aggregate number of
shares of common stock that may be issued pursuant to awards
granted under the 2018 Plan by 2,500,000 shares to 10,687,596
shares. |
|
Management |
|
For |
|
For |
|
4. |
|
To
ratify the selection of KPMG LLP as the Company's independent
registered public accounting firm for the current year ending
December 31, 2022. |
|
Management |
|
For |
|
For |
|
Security |
81181C104 |
Meeting
Type |
Annual |
Ticker
Symbol |
SGEN |
Meeting
Date |
13-May-2022 |
Record
Date |
17-Mar-2022 |
|
|